Mark Rosenbach

3.9k total citations · 1 hit paper
23 papers, 2.5k citations indexed

About

Mark Rosenbach is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Mark Rosenbach has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Mark Rosenbach's work include Sphingolipid Metabolism and Signaling (14 papers), Lipid Membrane Structure and Behavior (9 papers) and Fungal Biology and Applications (5 papers). Mark Rosenbach is often cited by papers focused on Sphingolipid Metabolism and Signaling (14 papers), Lipid Membrane Structure and Behavior (9 papers) and Fungal Biology and Applications (5 papers). Mark Rosenbach collaborates with scholars based in United States, Spain and Germany. Mark Rosenbach's co-authors include Suzanne Mandala, Richard Hajdu, James A. Milligan, Rosemary Thornton, Deborah Card, Jeffrey J. Hale, James D. Bergstrom, Gan-Ju Shei, Hugh Rosen and Christopher L. Lynch and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Mark Rosenbach

23 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

2002 1.4k citations Suzanne Mandala, Richard Hajdu et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Rosenbach United States	17	1.9k	539	458	373	233	23	2.5k
James A. Milligan United States	19	1.7k 0.9×	481 0.9×	324 0.7×	391 1.0×	175 0.8×	24	2.3k
Rosemary Thornton United States	12	2.0k 1.0×	477 0.9×	569 1.2×	314 0.8×	257 1.1×	15	2.5k
Eva E. Prieschl Austria	19	1.6k 0.8×	654 1.2×	309 0.7×	174 0.5×	226 1.0×	26	2.2k
Mir F. Ahmad United States	11	2.1k 1.1×	418 0.8×	364 0.8×	75 0.2×	143 0.6×	13	2.8k
Daniel Canals United States	27	1.6k 0.8×	168 0.3×	438 1.0×	169 0.5×	426 1.8×	48	2.0k
Susumu Tanimura Japan	25	1.2k 0.6×	172 0.3×	253 0.6×	123 0.3×	112 0.5×	46	1.8k
Shalini Mathias United States	8	2.1k 1.1×	477 0.9×	380 0.8×	86 0.2×	380 1.6×	8	2.4k
Christina Voelkel‐Johnson United States	34	2.0k 1.0×	539 1.0×	411 0.9×	79 0.2×	119 0.5×	81	2.8k
A Kaplan United States	18	714 0.4×	371 0.7×	410 0.9×	253 0.7×	720 3.1×	22	1.8k
Patricia G. McCaffrey United States	21	2.2k 1.1×	1.1k 2.0×	196 0.4×	187 0.5×	101 0.4×	25	3.0k

Countries citing papers authored by Mark Rosenbach

Since Specialization

Citations

This map shows the geographic impact of Mark Rosenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rosenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rosenbach more than expected).

Fields of papers citing papers by Mark Rosenbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Rosenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rosenbach. The network helps show where Mark Rosenbach may publish in the future.

Co-authorship network of co-authors of Mark Rosenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Rosenbach. A scholar is included among the top collaborators of Mark Rosenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Rosenbach. Mark Rosenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Váchal, Petr, Jeffrey J. Hale, Lin Yan, et al.. (2006). Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorganic & Medicinal Chemistry Letters. 16(14). 3684–3687. 29 indexed citations

Yan, Lin, George Doherty, Jeffrey J. Hale, et al.. (2006). Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes. Bioorganic & Medicinal Chemistry Letters. 16(14). 3679–3683. 15 indexed citations

Colandrea, Vincent J., Lin Yan, Jeffrey J. Hale, et al.. (2006). 2,5-Disubstituted pyrrolidine carboxylates as potent, orally active sphingosine-1-phosphate (S1P) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(11). 2905–2908. 18 indexed citations

Yan, Lin, Richard J. Budhu, Christopher L. Lynch, et al.. (2006). 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters. 16(13). 3564–3568. 18 indexed citations

Yan, Lin, Jeffrey J. Hale, Sander G. Mills, et al.. (2006). SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 17(3). 828–831. 18 indexed citations

Hale, Jeffrey J., William Neway, Sander G. Mills, et al.. (2004). Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorganic & Medicinal Chemistry Letters. 14(12). 3351–3355. 64 indexed citations

Allende, María L., Teiji Sasaki, Hiromichi Kawai, et al.. (2004). Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720. Journal of Biological Chemistry. 279(50). 52487–52492. 381 indexed citations

Hale, Jeffrey J., Lin Yan, William Neway, et al.. (2004). Synthesis, stereochemical determination and biochemical characterization of the enantiomeric phosphate esters of the novel immunosuppressive agent FTY720. Bioorganic & Medicinal Chemistry. 12(18). 4803–4807. 39 indexed citations

Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3501–3505. 39 indexed citations

10.

Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3495–3499. 26 indexed citations

11.

Yan, Lin, Jeffrey J. Hale, Christopher L. Lynch, et al.. (2004). Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors. Bioorganic & Medicinal Chemistry Letters. 14(19). 4861–4866. 23 indexed citations

12.

Hale, Jeffrey J., Christopher L. Lynch, William Neway, et al.. (2004). A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists. Journal of Medicinal Chemistry. 47(27). 6662–6665. 65 indexed citations

13.

Mandala, Suzanne, Richard Hajdu, James D. Bergstrom, et al.. (2002). Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists. Science. 296(5566). 346–349. 1398 indexed citations breakdown →

14.

Vicente, M. Francisca, Angeles Cabello, Gonzalo Platas, et al.. (2001). Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum. Journal of Applied Microbiology. 91(5). 806–813. 32 indexed citations

15.

Shafiee, Ali, et al.. (2001). Microbial hydroxylation of rustmicin (galbonolide A) and galbonolide B, two antifungal products produced by Micromonospora sp.. Journal of Molecular Catalysis B Enzymatic. 11(4-6). 237–242. 7 indexed citations

16.

Peláez, Fernando, José López-Collado, Gonzalo Platas, et al.. (2001). Studies on Tricellulortus pepoformis, a tropical mitosporic fungus. Nova Hedwigia. 72(1-2). 217–230. 5 indexed citations

17.

Mandala, Suzanne, Rosemary Thornton, James A. Milligan, et al.. (1998). Rustmicin, a Potent Antifungal Agent, Inhibits Sphingolipid Synthesis at Inositol Phosphoceramide Synthase. Journal of Biological Chemistry. 273(24). 14942–14949. 97 indexed citations

18.

Harris, Guy H., Ali Shafiee, M. Angeles Cabello, et al.. (1998). Inhibition of Fungal Sphingolipid Biosynthesis by Rustmicin, Galbonolide B and Their New 21-Hydroxy Analogs.. The Journal of Antibiotics. 51(9). 837–844. 30 indexed citations

19.

Mandala, Suzanne, Rosemary Thornton, Mark Rosenbach, et al.. (1997). Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis. Journal of Biological Chemistry. 272(51). 32709–32714. 113 indexed citations

20.

Rosenbach, Mark, et al.. (1990). Elevated uridine nucleotide pools in fluorouracil/fluorouridine resistant mutants ofNocardia lactamdurans. Journal of Industrial Microbiology & Biotechnology. 5(5). 313–321. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact